** Shares of biotech company Bio-Techne rise 4.6% to $74 premarket
** TECH beat Q1 profit estimates, helped by growth in its diagnostics and spatial biology segment
** On an adjusted basis, TECH posts profit of 42 cents per share, above estimates of 38 cents per share - LSEG data
** Total revenue of $289.46 million beats estimates of $280.3 million
** Stock down 8.3% YTD
(Reporting by Jaiveer Singh Shekhawat in Bengaluru)
((JaiveerSingh.Shekhawat@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.